EpCAM, a Potential Therapeutic Target for Esophageal Squamous Cell Carcinoma

[1] Pennathur A(2013)Oesophageal carcinoma Lancet. 381 400-412

[2] Gibson MK(2004)Treatment of localized esophageal cancer Semin Oncol. 31 554-565

[3] Jobe BA(2003)Esophageal cancer N Engl J Med. 349 2241-2252

[4] Luketich JD(2012)Concurrent Biological Targeting Therapy of Squamous Cell Carcinoma of the Esophagus with Cetuximab and Trastuzumab Oncol Rep. 28 49-54

[5] Brenner B(2009)Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie Ann Oncol. 20 1667-1673

[6] Ilson DH(1979)Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies Proc Natl Acad Sci U S A. 76 1438-1442

[7] Minsky BD(2012)Epithelial cell adhesion molecule expression (CD326) in cancer: a short review Cancer Treat Rev. 38 68-75

[8] Enzinger PC(2012)EpCAM and its potential role in tumor-initiating cells Cell Adh Migr. 6 30-38

[9] Mayer RJ(2009)The emerging role of EpCAM in cancer and stem cell signaling Cancer Res. 69 5627-5629

[10] Yamazaki M(2006)Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Br J Cancer. 94 128-135

[1] Pennathur A(2013)Oesophageal carcinoma Lancet. 381 400-412

[2] Gibson MK(2004)Treatment of localized esophageal cancer Semin Oncol. 31 554-565

[3] Jobe BA(2003)Esophageal cancer N Engl J Med. 349 2241-2252

[4] Luketich JD(2012)Concurrent Biological Targeting Therapy of Squamous Cell Carcinoma of the Esophagus with Cetuximab and Trastuzumab Oncol Rep. 28 49-54

[5] Brenner B(2009)Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie Ann Oncol. 20 1667-1673

[6] Ilson DH(1979)Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies Proc Natl Acad Sci U S A. 76 1438-1442

[7] Minsky BD(2012)Epithelial cell adhesion molecule expression (CD326) in cancer: a short review Cancer Treat Rev. 38 68-75

[8] Enzinger PC(2012)EpCAM and its potential role in tumor-initiating cells Cell Adh Migr. 6 30-38

[9] Mayer RJ(2009)The emerging role of EpCAM in cancer and stem cell signaling Cancer Res. 69 5627-5629

[10] Yamazaki M(2006)Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers Br J Cancer. 94 128-135